Raltitrexed and Pemetrexed Studies in Mesothelioma Have Not Shown Improved Quality of Life nor Prolonged Survival Compared With Effective Pleurodesis With Thoracoscopic Talc Poudrage-Reference-Cited by-同舟云学术

Raltitrexed and Pemetrexed Studies in Mesothelioma Have Not Shown Improved Quality of Life nor Prolonged Survival Compared With Effective Pleurodesis With Thoracoscopic Talc Poudrage

Published:2006-10-01 Issue:28 Volume:24 Page:4667-4667
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Aelony Yossef¹

Affiliation:

1. Los Angeles County Harbor–UCLA Medical Center, Rancho Palos Verdes, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.08.0267

Reference3 articles.

1. Short-Term Treatment-Related Symptoms and Quality of Life: Results From an International Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study

2. Prolonged survival after talc poudrage for malignant pleural mesothelioma: Case series

3. Single-Center Experience With 250 Tunnelled Pleural Catheter Insertions for Malignant Pleural Effusion

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thematic series: Novel insights in pleural diseases;The Clinical Respiratory Journal;2019-05

2. Sensitization of mesothelioma cells to platinum-based chemotherapy by GSTπ knockdown;Biochemical and Biophysical Research Communications;2014-04

3. Glutathione S-transferase P1-1 as a target for mesothelioma treatment;Cancer Science;2012-12-24

4. Pleural Diseases in the Molecular Era – Time for More Answers: Introduction;Respiration;2012

5. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro;Cancer Letters;2010-08